Phosphorus Metabolism Disorders
Phosphorus
Lipid Metabolism Disorders
Calcium Metabolism Disorders
Metabolic Diseases
Parathyroid Hormone
Iron Metabolism Disorders
Glucose Metabolism Disorders
Calcium
Phosphorus, Dietary
Effects of partial and total colectomy on mineral and acid-base homoeostasis in the rat: magnesium deficiency, hyperphosphaturia and osteopathy, in the presence of high serum 1,25-dihydroxyvitamin D but normal parathyroid hormone. (1/41)
The effects of colectomy on acid-base status, extra-osseous and bone minerals, calciotropic hormones and bone morphology have not yet been studied. To rectify this, groups of normally fed male rats were subjected to distal (n=11), proximal (n=12) or total (n=12) colectomy. Sham-operated rats (n=12) served as controls. At 112 (+/-2) days after colectomy the following changes were noted: (1) weight gain was delayed; (2) faecal excretion of calcium and phosphorus was normal, whereas that of magnesium was increased; (3) intestinal calcium secretion and absorption of calcium and phosphorus were normal, but magnesium absorption was decreased; (4) urinary excretion of magnesium was also decreased, that of phosphorus was increased, and that of pyridinium and deoxypyridinium tended to be high; (5) the serum levels of ionized magnesium, total calcium, 25-hydroxyvitamin D and parathyroid hormone were normal, while that of 1,25-dihydroxyvitamin D was markedly elevated; and (6) bone magnesium and phosphorus content were decreased, but bone calcium was normal, and thus the bone calcium/phosphorus ratio was high. These abnormalities were associated with moderate metabolic acidosis, as reflected by high urinary ammonium, low citrate and low total CO(2), but normal blood gases. Significant structural abnormalities of bone were not detectable, but trabecular bone tended to show rarefication. Distal colectomy had the least effect, whereas proximal and total colectomies had a distinct effect, on these parameters. It is concluded that colectomy in the rat causes: (1) a syndrome of magnesium deficiency of intestinal origin, compensated metabolic acidosis, urinary phosphorus loss, and high circulating 1,25-dihydroxyvitamin D levels, with the degree depending on the extent of surgical resection; and (2) brittle bones, a feature characteristic of low bone magnesium and more generalized magnesium deficiency. The mechanisms leading to this syndrome are unknown, but altered tissue levels of magnesium and phosphorus may play a key role. (+info)Calcium acetate versus calcium carbonate in the control of hyperphosphatemia in hemodialysis patients. (2/41)
CONTEXT: Hyperphosphatemia has an important role in the development of bone and mineral abnormalities in end-stage renal disease (ESRD). OBJECTIVE: To compare the phosphorus binding power and the hypercalcemic effect of calcium acetate and calcium carbonate in hemodialysis patients. TYPE OF STUDY: Crossover, randomized, double-blind study. PLACE: A private hospital dialysis center. PARTICIPANTS: Fifty-two patients who were undergoing regular hemodialysis three times a week ([Ca++] dialysate = 3.5 mEq/L). PROCEDURES: Half of the patients were started on 5.6 g/day of calcium acetate and, after a 2 week washout period, received 6.2 g/day of calcium carbonate. The other half followed an inverse protocol. MAIN MEASUREMENTS: Clinical interviews were conducted 3 times a week to monitor for side effects. Determinations of serum urea, calcium, phosphorus, hematocrit, Kt/V and blood gas analysis were obtained before and after each treatment. RESULTS: Twenty-three patients completed the study. A significant increase in calcium plasma levels was only observed after treatment with calcium carbonate [9.34 mg/dl (SD 0.91) vs. 9.91 mg/dl (SD 0.79), P < 0.01]. The drop in phosphorus levels was substantial and significant for both salts [5.64 mg/dl (SD 1.54) vs. 4.60 mg/dl (SD 1.32), P < 0.01 and 5.89 mg/dl (SD 1.71) vs. 4.56 mg/dl (SD 1.57), P < 0.01, for calcium acetate and calcium carbonate respectively]. The percentage reduction in serum phosphorus (at the end of the study) per milliequivalent of salt administered per day tended to be higher with calcium acetate but statistical significance was not found. CONCLUSION: Calcium acetate can be a good alternative to calcium carbonate in the handling of hyperphosphatemia in ESRD patients. When calcium acetate is used, control of hyperphosphatemia can be achieved with a lower administration of calcium, perhaps with a lower risk of hypercalcemia. (+info)Management of hyperphosphataemia of chronic kidney disease: lessons from the past and future directions. (3/41)
A historical look at research in hyperphosphataemia of chronic kidney disease over the last 40 years shows remarkable advances in our understanding of this abnormality and in the technology used to manage it. Phosphate binders, which have become a mainstay in the management of hyperphosphataemia, have evolved from the early use of aluminium gels to calcium salts, to novel, non-absorbed, aluminium-free, calcium-free agents such as sevelamer hydrochloride, and to magnesium-, iron-, and lanthanum-based compounds. With recent advances, clinical management of this complication of chronic renal disease is evolving from adequate care to optimal care, such that new standards in phosphorous management are being set, and various parameters of patient care are being integrated to optimize outcomes and minimize side effects. This paper provides a historical view of the clinical management of hyperphosphataemia, and looks to advances in treatment that are changing the course of renal bone disease management. (+info)A prospective study of combination therapy for hyperphosphataemia with calcium-containing phosphate binders and sevelamer in hypercalcaemic haemodialysis patients. (4/41)
INTRODUCTION: Hyperphosphataemia is predictive of death, in haemodialysis (HD) patients. Sevelamer is a mineral-free phosphate binder not limited by the hypercalcaemia often encountered when utilizing calcium-containing phosphate binders. Highly positive calcium balance is associated with ectopic calcification and potentially accelerated vascular disease. Unfortunately, exclusive use of sevelamer entails a large cost differential, limiting its use in many centres. We report on a strategy of partial replacement of calcium with sevelamer for the management of hyperphosphataemia in hypercalcaemic chronic HD patients. METHODS: We identified 23 HD patients with serum calcium >2.6 mmol/l. Dietary phosphate and calcium intake were assessed and baseline serum calcium, phosphate and 1alpha calcidol and elemental calcium dose recorded. Fifty per cent of this initial calcium dose was exchanged for sevelamer. Vitamin D doses were left unchanged. If serum calcium was still >2.6 mmol/l after 4 weeks a further 50% of calcium was exchanged. If serum phosphate was >2 mmol/l the sevelamer dose was increased by 25%. The patients were followed up for a further 4 weeks. RESULTS: Seven patients complained of gastrointestinal intolerance of sevelamer. Serum calcium fell from a mean value of 2.8+/-0.04 (2.64-3.54) mmol/l to 2.56+/-0.03 (2.4-2.9) mmol/l, P<0.0005. The hypercalcaemic percentage of patients fell from 100 to 26%. Mean serum phosphate was not significantly changed, 1.59+/-0.1 (0.57-2.6) mmol/l to 1.63+/-0.11 (0.55-2.68) mmol/l, 17-22% of patients having serum phosphate >2 mmol/l. Serum intact parathyroid hormone increased from 166+/-47 (12-933) ng/l to 276+/-104 (20-1013) ng/l, P=0.02. Mean sevelamer dose was 2.77+/-0.36 (0-5.6) g per day. Elemental calcium dose fell from 2.05+/-0.23 (0.5-4.5) g to 1.03+/-0.1 (0.5-2.5) g, P<0.0001. CONCLUSION: A regimen based on the combination of sevelamer and calcium is capable of effectively managing hyperphosphataemia, without hypercalcaemia, in the majority of hypercalcaemic HD patients. Such a minimally calcaemic approach might reduce the financial burden of sevelamer therapy, and enable a wider range of patients to be treated. (+info)Hyperphosphataemia as a cardiovascular risk factor -- how to manage the problem. (5/41)
Hyperphosphataemia is a frequent and important cardiovascular risk factor in patients with chronic kidney disease (CKD). High phosphate levels may influence vascular calcifications by two separate mechanisms: by worsening secondary hyperparathyroidism, which in turn facilitates calcification, and by promoting calcium phosphate deposition in pre-formed endothelial plaques and in the arterial wall. Recent studies have shown that hyperphosphataemia induces the proliferation and differentiation of endothelial vascular cells into osteoblast-like cells, promoting vascular calcification. High phosphate levels also increase the risk of mortality in patients with CKD. To reduce the negative impact of high phosphate, serum phosphate levels should be <5 mg/dl and serum calcium <10 mg/dl. This allows the calcium x phosphate product to be maintained at < or =50 mg(2)/dl(2), reducing the risk of vascular, valvular, and extraskeletal calcification. A multiple-factor approach can be used to reduce serum phosphate: (i). decrease bone resorption by maintaining adequate serum parathyroid hormone levels; (ii). reduce phosphorous intake in the diet, (iii). use phosphate binders efficiently; and (iv). avoid under-dialysis. The patient's diet should be high in nutrition but with the lowest possible phosphorous content. Doses of phosphate binders should be tailored to individual dietary habits and must be taken during meals in a dose proportional to the phosphorous content of the meal. Because of the risk of increased extraskeletal calcification, calcium-containing phosphate-binder intake should not exceed 2-3 g/day. Sevelamer hydrochloride, a non-calcium and non-aluminium phosphate binder with a potency similar to that of calcium salts has shown beneficial effects on lipid profiles. Better control of serum phosphate is achieved in patients on continuous ambulatory peritoneal dialysis than in those on haemodialysis. Removal of phosphate is directly correlated with duration and frequency of dialysis sessions. Thus, it is advisable not to reduce the duration of dialysis sessions to <4 h three times per week. (+info)Decreased absorption of calcium, magnesium, zinc and phosphorus by humans due to increased fiber and phosphorus consumption as wheat bread. (6/41)
During a 20 day period of high fiber consumption in the form of bread made partly from wheaten wholemeal, two men developed negative balances of calcium, magnesium, zinc and phosphorus due to increased fecal excretion of each element. The fecal losses correlated closely with fecal dry matter and phosphorus. Fecal dry matter, in turn, was directly proportional to fecal fiber excretion. Balances of nitrogen remained positive. Mineral elements were well-utilized by the same subjects during a 20-day period of white bread consumption. (+info)Molecular targets of hyperphosphataemia in chronic renal failure. (7/41)
Dietary phosphate restriction can prevent or retard the progress of chronic renal failure (CRF) and secondary hyperparathyroidism. The klotho gene is involved in the development of a syndrome resembling human ageing, and klotho mutant mice show abnormal calcium/vitamin D metabolism, developing hyperphosphataemia and vascular calcification. Phosphate retention rescues the phenotype of klotho mice. The level of expression of klotho RNA was greatly reduced in the kidneys of all CRF patients. Dietary P(i) restriction induced klotho expression, which enhances the beneficial effect of P(i) restriction in patients with CRF and/or on haemodialysis. (+info)Hyperphosphataemia and treatment with sevelamer in haemodialysis patients. (8/41)
More than 60% of patients on chronic haemodialysis (HD) have a serum phosphate level above 5.5 mg/dl (1.75 mmol/l), which recently has been recommended as an appropriate target in patients with end-stage renal disease (ESRD). Preventing hyperphosphataemia and elevated Ca x P product not only ameliorates the progression of secondary hyperparathyroidism and bone disease, but also appears to reduce cardio-vascular morbidity and mortality from vascular calcifications. Dietary phosphate restriction and the administration of aluminium and calcium salts have been the principal means of phosphate control over the last decade. Unfortunately, the protean disturbances of toxic aluminium accumulation in the body virtually eliminated aluminium from clinical practice. Calcium-based therapy, although well tolerated, results in frequent hypercalcaemia when administered concurrently with vitamin D analogues, despite a decrease in the concentration of dialysate calcium. Sevelamer (Renagel((R))) has been a novel, non-absorbable calcium- and aluminium-free synthetic polymer. In initial studies, sevelamer reduced serum phosphate, Ca x P product and parathyroid hormone (PTH) in a manner comparable with calcium acetate therapy. However, the effect on PTH levels may prove to be inconsistent. It seems somewhat less effective in binding phosphate than aluminium, although no direct comparisons have been made. In a recent study, it attenuated the progression of vascular calcification in HD patients. It also binds bile acids, resulting in substantially lower low-density lipo-protein cholesterol levels. The major obstacle to its current use is a substantial increase in the cost associated with sevelamer therapy. (+info)Phosphorus metabolism disorders refer to a group of conditions that affect the body's ability to properly regulate the levels and utilization of phosphorus. Phosphorus is an essential mineral that plays a critical role in many biological processes, including energy production, bone formation, and nerve function.
Disorders of phosphorus metabolism can result from genetic defects, kidney dysfunction, vitamin D deficiency, or other medical conditions. These disorders can lead to abnormal levels of phosphorus in the blood, which can cause a range of symptoms, including muscle weakness, bone pain, seizures, and respiratory failure.
Examples of phosphorus metabolism disorders include:
1. Hypophosphatemia: This is a condition characterized by low levels of phosphorus in the blood. It can be caused by various factors, such as malnutrition, vitamin D deficiency, and kidney dysfunction.
2. Hyperphosphatemia: This is a condition characterized by high levels of phosphorus in the blood. It can be caused by kidney failure, tumor lysis syndrome, and certain medications.
3. Hereditary hypophosphatemic rickets: This is a genetic disorder that affects the body's ability to regulate vitamin D and phosphorus metabolism. It can lead to weakened bones and skeletal deformities.
4. Oncogenic osteomalacia: This is a rare condition that occurs when tumors produce substances that interfere with phosphorus metabolism, leading to bone pain and weakness.
Treatment for phosphorus metabolism disorders depends on the underlying cause of the disorder and may include dietary changes, supplements, medications, or surgery.
Phosphorus is an essential mineral that is required by every cell in the body for normal functioning. It is a key component of several important biomolecules, including adenosine triphosphate (ATP), which is the primary source of energy for cells, and deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), which are the genetic materials in cells.
Phosphorus is also a major constituent of bones and teeth, where it combines with calcium to provide strength and structure. In addition, phosphorus plays a critical role in various metabolic processes, including energy production, nerve impulse transmission, and pH regulation.
The medical definition of phosphorus refers to the chemical element with the atomic number 15 and the symbol P. It is a highly reactive non-metal that exists in several forms, including white phosphorus, red phosphorus, and black phosphorus. In the body, phosphorus is primarily found in the form of organic compounds, such as phospholipids, phosphoproteins, and nucleic acids.
Abnormal levels of phosphorus in the body can lead to various health problems. For example, high levels of phosphorus (hyperphosphatemia) can occur in patients with kidney disease or those who consume large amounts of phosphorus-rich foods, and can contribute to the development of calcification of soft tissues and cardiovascular disease. On the other hand, low levels of phosphorus (hypophosphatemia) can occur in patients with malnutrition, vitamin D deficiency, or alcoholism, and can lead to muscle weakness, bone pain, and an increased risk of infection.
Lipid metabolism disorders are a group of conditions that result from abnormalities in the breakdown, transport, or storage of lipids (fats) in the body. These disorders can lead to an accumulation of lipids in various tissues and organs, causing them to function improperly.
There are several types of lipid metabolism disorders, including:
1. Hyperlipidemias: These are conditions characterized by high levels of cholesterol or triglycerides in the blood. They can increase the risk of cardiovascular disease and pancreatitis.
2. Hypercholesterolemia: This is a condition characterized by high levels of low-density lipoprotein (LDL) cholesterol, also known as "bad" cholesterol, in the blood. It can increase the risk of cardiovascular disease.
3. Hypocholesterolemias: These are conditions characterized by low levels of cholesterol in the blood. Some of these disorders may be associated with an increased risk of cancer and neurological disorders.
4. Hypertriglyceridemias: These are conditions characterized by high levels of triglycerides in the blood. They can increase the risk of pancreatitis and cardiovascular disease.
5. Lipodystrophies: These are conditions characterized by abnormalities in the distribution of body fat, which can lead to metabolic abnormalities such as insulin resistance, diabetes, and high levels of triglycerides.
6. Disorders of fatty acid oxidation: These are conditions that affect the body's ability to break down fatty acids for energy, leading to muscle weakness, liver dysfunction, and in some cases, life-threatening neurological complications.
Lipid metabolism disorders can be inherited or acquired, and their symptoms and severity can vary widely depending on the specific disorder and the individual's overall health status. Treatment may include lifestyle changes, medications, and dietary modifications to help manage lipid levels and prevent complications.
Calcium metabolism disorders refer to a group of medical conditions that affect the body's ability to properly regulate the levels of calcium in the blood and tissues. Calcium is an essential mineral that plays a critical role in many bodily functions, including bone health, muscle contraction, nerve function, and blood clotting.
There are several types of calcium metabolism disorders, including:
1. Hypocalcemia: This is a condition characterized by low levels of calcium in the blood. It can be caused by various factors such as vitamin D deficiency, hypoparathyroidism, and certain medications. Symptoms may include muscle cramps, spasms, and tingling sensations in the fingers and toes.
2. Hypercalcemia: This is a condition characterized by high levels of calcium in the blood. It can be caused by various factors such as hyperparathyroidism, cancer, and certain medications. Symptoms may include fatigue, weakness, confusion, and kidney stones.
3. Osteoporosis: This is a condition characterized by weak and brittle bones due to low calcium levels in the bones. It can be caused by various factors such as aging, menopause, vitamin D deficiency, and certain medications. Symptoms may include bone fractures and loss of height.
4. Paget's disease: This is a condition characterized by abnormal bone growth and deformities due to disordered calcium metabolism. It can be caused by various factors such as genetics, age, and certain medications. Symptoms may include bone pain, fractures, and deformities.
Treatment for calcium metabolism disorders depends on the underlying cause of the condition. It may involve supplements, medication, dietary changes, or surgery. Proper diagnosis and management are essential to prevent complications such as kidney stones, bone fractures, and neurological damage.
Metabolic diseases are a group of disorders caused by abnormal chemical reactions in your body's cells. These reactions are part of a complex process called metabolism, where your body converts the food you eat into energy.
There are several types of metabolic diseases, but they most commonly result from:
1. Your body not producing enough of certain enzymes that are needed to convert food into energy.
2. Your body producing too much of certain substances or toxins, often due to a genetic disorder.
Examples of metabolic diseases include phenylketonuria (PKU), diabetes, and gout. PKU is a rare condition where the body cannot break down an amino acid called phenylalanine, which can lead to serious health problems if left untreated. Diabetes is a common disorder that occurs when your body doesn't produce enough insulin or can't properly use the insulin it produces, leading to high blood sugar levels. Gout is a type of arthritis that results from too much uric acid in the body, which can form crystals in the joints and cause pain and inflammation.
Metabolic diseases can be inherited or acquired through environmental factors such as diet or lifestyle choices. Many metabolic diseases can be managed with proper medical care, including medication, dietary changes, and lifestyle modifications.
Parathyroid hormone (PTH) is a polypeptide hormone that plays a crucial role in the regulation of calcium and phosphate levels in the body. It is produced and secreted by the parathyroid glands, which are four small endocrine glands located on the back surface of the thyroid gland.
The primary function of PTH is to maintain normal calcium levels in the blood by increasing calcium absorption from the gut, mobilizing calcium from bones, and decreasing calcium excretion by the kidneys. PTH also increases phosphate excretion by the kidneys, which helps to lower serum phosphate levels.
In addition to its role in calcium and phosphate homeostasis, PTH has been shown to have anabolic effects on bone tissue, stimulating bone formation and preventing bone loss. However, chronic elevations in PTH levels can lead to excessive bone resorption and osteoporosis.
Overall, Parathyroid Hormone is a critical hormone that helps maintain mineral homeostasis and supports healthy bone metabolism.
Iron metabolism disorders are a group of medical conditions that affect the body's ability to absorb, transport, store, or utilize iron properly. Iron is an essential nutrient that plays a crucial role in various bodily functions, including oxygen transportation and energy production. However, imbalances in iron levels can lead to several health issues.
There are two main types of iron metabolism disorders:
1. Iron deficiency anemia (IDA): This condition occurs when the body lacks adequate iron to produce sufficient amounts of hemoglobin, a protein in red blood cells responsible for carrying oxygen throughout the body. Causes of IDA may include inadequate dietary iron intake, blood loss, or impaired iron absorption due to conditions like celiac disease or inflammatory bowel disease.
2. Hemochromatosis: This is a genetic disorder characterized by excessive absorption and accumulation of iron in various organs, including the liver, heart, and pancreas. Over time, this excess iron can lead to organ damage and diseases such as cirrhosis, heart failure, diabetes, and arthritis. Hemochromatosis is typically caused by mutations in the HFE gene, which regulates iron absorption in the intestines.
Other iron metabolism disorders include:
* Anemia of chronic disease (ACD): A type of anemia that occurs in individuals with chronic inflammation or infection, where iron is not efficiently used for hemoglobin production due to altered regulation.
* Sideroblastic anemias: These are rare disorders characterized by the abnormal formation of ringed sideroblasts (immature red blood cells containing iron-laden mitochondria) in the bone marrow, leading to anemia and other symptoms.
* Iron-refractory iron deficiency anemia (IRIDA): A rare inherited disorder caused by mutations in the TMPRSS6 gene, resulting in impaired regulation of hepcidin, a hormone that controls iron absorption and distribution in the body. This leads to both iron deficiency and iron overload.
Proper diagnosis and management of iron metabolism disorders are essential to prevent complications and maintain overall health. Treatment options may include dietary modifications, iron supplementation, phlebotomy (bloodletting), or chelation therapy, depending on the specific disorder and its severity.
Phosphates, in a medical context, refer to the salts or esters of phosphoric acid. Phosphates play crucial roles in various biological processes within the human body. They are essential components of bones and teeth, where they combine with calcium to form hydroxyapatite crystals. Phosphates also participate in energy transfer reactions as phosphate groups attached to adenosine diphosphate (ADP) and adenosine triphosphate (ATP). Additionally, they contribute to buffer systems that help maintain normal pH levels in the body.
Abnormal levels of phosphates in the blood can indicate certain medical conditions. High phosphate levels (hyperphosphatemia) may be associated with kidney dysfunction, hyperparathyroidism, or excessive intake of phosphate-containing products. Low phosphate levels (hypophosphatemia) might result from malnutrition, vitamin D deficiency, or certain diseases affecting the small intestine or kidneys. Both hypophosphatemia and hyperphosphatemia can have significant impacts on various organ systems and may require medical intervention.
Glucose metabolism disorders are a group of conditions that result from abnormalities in the body's ability to produce, store, or use glucose, which is a simple sugar that serves as the primary source of energy for the body's cells. These disorders can be categorized into two main types: those caused by insufficient insulin production (such as type 1 diabetes) and those caused by impaired insulin action (such as type 2 diabetes).
In healthy individuals, glucose is absorbed from food during digestion and enters the bloodstream. The pancreas responds to this increase in blood glucose levels by releasing insulin, a hormone that signals cells throughout the body to take up glucose from the bloodstream and use it for energy production or storage.
Glucose metabolism disorders can disrupt this process at various stages, leading to high blood glucose levels (hyperglycemia) or low blood glucose levels (hypoglycemia). Some common examples of these disorders include:
1. Diabetes Mellitus: A group of metabolic disorders characterized by high blood glucose levels due to insufficient insulin production, impaired insulin action, or both. Type 1 diabetes results from the autoimmune destruction of pancreatic beta-cells that produce insulin, while type 2 diabetes is caused by a combination of insulin resistance and inadequate insulin secretion.
2. Gestational Diabetes: A form of high blood glucose that develops during pregnancy due to hormonal changes that impair insulin action.
3. Prediabetes: A condition where blood glucose levels are higher than normal but not yet high enough to be classified as diabetes.
4. Hypoglycemia: Abnormally low blood glucose levels, which can result from certain medications, hormonal deficiencies, or other medical conditions.
5. Glycogen Storage Diseases: A group of rare inherited metabolic disorders that affect the body's ability to store and break down glycogen, a complex carbohydrate that serves as an energy reserve in muscles and the liver.
6. Maturity-Onset Diabetes of the Young (MODY): A group of monogenic forms of diabetes caused by mutations in specific genes involved in insulin secretion or action.
7. Glucose Galactose Malabsorption: An inherited disorder that impairs the absorption of glucose and galactose, leading to severe diarrhea, dehydration, and high blood glucose levels.
8. Fructose Intolerance: A condition where the body cannot metabolize fructose properly due to a deficiency in the enzyme aldolase B, resulting in abdominal pain, diarrhea, and high blood glucose levels.
Calcium is an essential mineral that is vital for various physiological processes in the human body. The medical definition of calcium is as follows:
Calcium (Ca2+) is a crucial cation and the most abundant mineral in the human body, with approximately 99% of it found in bones and teeth. It plays a vital role in maintaining structural integrity, nerve impulse transmission, muscle contraction, hormonal secretion, blood coagulation, and enzyme activation.
Calcium homeostasis is tightly regulated through the interplay of several hormones, including parathyroid hormone (PTH), calcitonin, and vitamin D. Dietary calcium intake, absorption, and excretion are also critical factors in maintaining optimal calcium levels in the body.
Hypocalcemia refers to low serum calcium levels, while hypercalcemia indicates high serum calcium levels. Both conditions can have detrimental effects on various organ systems and require medical intervention to correct.
Dietary Phosphorus is a mineral that is an essential nutrient for human health. It is required for the growth, maintenance, and repair of body tissues, including bones and teeth. Phosphorus is also necessary for the production of energy, the formation of DNA and RNA, and the regulation of various physiological processes.
In the diet, phosphorus is primarily found in protein-containing foods such as meat, poultry, fish, dairy products, legumes, and nuts. It can also be found in processed foods that contain additives such as phosphoric acid, which is used to enhance flavor or as a preservative.
The recommended daily intake of phosphorus for adults is 700 milligrams (mg) per day. However, it's important to note that excessive intake of phosphorus, particularly from supplements and fortified foods, can lead to health problems such as kidney damage and calcification of soft tissues. Therefore, it's recommended to obtain phosphorus primarily from whole foods rather than supplements.
Phosphorus compounds refer to chemical substances that contain phosphorus (P) combined with one or more other elements. Phosphorus can form a variety of compounds due to its ability to exist in several oxidation states, most commonly +3 and +5.
In biological systems, phosphorus is an essential element for life, playing crucial roles in energy transfer, metabolism, and structural components of cells. Some common examples of phosphorus compounds include:
1. Phosphoric acid (H3PO4): A weak triprotic acid that forms salts called phosphates when combined with metal ions or basic radicals.
2. Phosphates (PO4^3-): The salt or ester form of phosphoric acid, widely found in nature and essential for various biological processes such as bone formation, energy metabolism, and nucleic acid synthesis.
3. Phosphorus pentachloride (PCl5): A pungent, white crystalline solid used in organic chemistry as a chlorinating agent.
4. Phosphorus trichloride (PCl3): A colorless liquid with a suffocating odor, used in the production of various chemical compounds, including pharmaceuticals and agrochemicals.
5. Dicalcium phosphate (CaHPO4): A calcium salt of phosphoric acid, commonly found in mineral supplements and used as a dietary supplement for animals and humans.
6. Adenosine triphosphate (ATP): A high-energy molecule that stores and transfers energy within cells, playing a critical role in metabolic processes such as muscle contraction and biosynthesis.
Phosphorus compounds have numerous applications across various industries, including agriculture, food processing, pharmaceuticals, and chemical manufacturing.
Osteitis fibrosa cystica
Renal osteodystrophy
Chronic kidney disease
Metabolic disorder
Charles Enrique Dent
Chronic kidney disease-mineral and bone disorder
Mitral annular calcification
Fibroblast growth factor 23
Goulstonian Lecture
Sucroferric oxyhydroxide
Osteodystrophy
Fatty liver disease
In vivo magnetic resonance spectroscopy
Wernicke encephalopathy
Rickets
Paricalcitol
Fucokinase
Cat food
Phosphonate
Osteomalacia
Calcitonin
German Shepherd
Phosphate diabetes
Iodine
Human skeleton
Nutrient sensing
Bioinorganic chemistry
Beer
List of ICD-9 codes 240-279: endocrine, nutritional and metabolic diseases, and immunity disorders
Acetylcholinesterase inhibitor
Phosphorus blood test: MedlinePlus Medical Encyclopedia
Article - Billing and Coding: Vitamin D Assay Testing (A57484)
P RXQ RX
USMLE | Multisystem Processes & Disorders
Dr. Thomas Knox, MD - Cardiology Specialist in Hartford, CT | Healthgrades
Dialysis Complications of Chronic Renal Failure: Practice Essentials, Electrolyte Abnormalities, Neurologic Complications
Bone Mineralization and Related Disorders: Practice Essentials, Vitamin D Metabolism, Pathophysiology
Dr. Tina Han, MD, Nephrology Specialist - Mount Prospect, IL | Sharecare
Dr. Paul Antalik, MD, Pediatrics Specialist - Pittsburgh, PA | Sharecare
Critical Care - 1st Edition - Robert Murtaugh - Routledge Book
Pediatric Hypocalcemia: Practice Essentials, Background, Pathophysiology
Dr. Mohammad Farooq, MD - Pulmonologist in Richmond, VA | Healthgrades
NIOSHTIC-2 Search Results - Full View
Osteitis fibrosa cystica - Wikipedia
Pediatric Nephrology, Fifth Edition, by Elis D. Avner, William E. Harmon, Patrick Niaudet
Hypophosphatemia in Animals - Metabolic Disorders - Merck Veterinary Manual
Osteopenia - premature infants: MedlinePlus Medical Encyclopedia
2012 ICD-9-CM Diagnosis Code 272.9 : Unspecified disorder of lipoid metabolism
Advanced Search Results - Public Health Image Library(PHIL)
Phosphorus - Health Professional Fact Sheet
Metabolic Bone Disease Clinic - Patient Care - Endocrinology, Diabetes, and Metabolism - Department of Medicine - Rochester, NY...
Staff Profile - Newcastle Magnetic Resonance Centre - Newcastle University
Safety of SGLT2i with regard to bone and mineral metabolism... : Current Opinion in Nephrology and Hypertension
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
Overview of Disorders of Phosphate Concentration - Endocrine and Metabolic Disorders - MSD Manual Professional Edition
Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and...
Baby’s Pregnancy Calendar
Should You Take Calcium Phosphate?
Serum7
- Cite this: Tumor-Induced Osteomalacia: The Importance of Measuring Serum Phosphorus Level - Medscape - Oct 01, 2007. (medscape.com)
- The combination of high phosphorus intakes with low calcium intakes increases serum PTH levels, but evidence is mixed on whether the increased hormone levels decrease bone mineral density [ 2 , 4-6 ]. (nih.gov)
- Although phosphorus status is not typically assessed, phosphate can be measured in both serum and plasma [ 10 ]. (nih.gov)
- However, plasma and serum phosphate levels do not necessarily reflect whole-body phosphorus content [ 1 , 11 ]. (nih.gov)
- The mineral and bone disorders may occur when the kidneys fail to maintain serum calcium and phosphorus levels. (nih.gov)
- The kidneys activate vitamin D [1,25(OH) 2 D or calcitriol] and maintain serum calcium and phosphorus levels. (nih.gov)
- Nine out of the 14 patients (64.29%) in the treatment group achieved the K/DOQI serum phosphorus goal. (nih.gov)
Parathyroid hormone3
- Phosphorus and calcium are interrelated because hormones, such as vitamin D and parathyroid hormone (PTH), regulate the metabolism of both minerals. (nih.gov)
- 3. Have a known or suspected disorder of mineral metabolism, as demonstrated by any one of the following: laboratory measurement above or below the reference values for either blood or urine calcium, phosphorus, magnesium, parathyroid hormone or vitamin D, or other measures of mineral metabolism, and/or a medical or family history consistent with or suggestive of a disorder of mineral metabolism. (nih.gov)
- The interrelationships among vitamin D, calcium, phosphorus, and parathyroid hormone (PTH) are altered in CKD and complex in nature. (nih.gov)
Abnormal5
- There are three osteomalacia syndromes associated with renal phosphate wasting and abnormal vitamin D metabolism: TIO, ADHR and X-linked hypophosphatemia (XLH). (medscape.com)
- Kidney, liver, and certain bone diseases can cause abnormal phosphorus levels. (medlineplus.gov)
- Your body can use this fuel right away, or it can store the energy in your body tissues, such as your liver, muscles and body fat.a metabolic disorder occurs when abnormal chemical reactions in your body disrupt this process. (icd9data.com)
- Non-traditional risk factors for CVD include albuminuria, anemia and abnormal metabolism of calcium and phosphorus. (nih.gov)
- There is an association between abnormal lactate response to exercise, reflecting impaired muscle energy metabolism, and the presence of enterovirus sequences in muscle in a proportion of CFS patients. (bmj.com)
Phosphate7
- The phosphorus blood test measures the amount of phosphate in the blood. (medlineplus.gov)
- Disorders of calcium, magnesium, and phosphate balance. (medlineplus.gov)
- Many different types of foods contain phosphorus, mainly in the form of phosphates and phosphate esters [ 1 ]. (nih.gov)
- Most phosphorus in the body is complexed with oxygen as phosphate. (msdmanuals.com)
- Phosphate is also involved in aerobic and anaerobic energy metabolism. (msdmanuals.com)
- Phosphate depletion can occur in various disorders and normally results in conservation of phosphate by the kidneys. (msdmanuals.com)
- Low levels of phosphate in the blood (hypophosphatemia) can lead to abnormalities in bone metabolism. (uchicago.edu)
Tumor-Induced Osteomalacia2
- Jones suffered from tumor-induced osteomalacia, a disorder caused by a benign tumor that produces the hormone FGF23, which affects the metabolism of phosphorus and vitamin D and ultimately bone strength. (nih.gov)
- Doctors suspected an underlying skeletal disorder, and when her blood phosphorus level came back low, they thought of tumor-induced osteomalacia. (nih.gov)
Thyroid6
- Why choose Johns Hopkins for treatment of thyroid disorders? (hopkinsmedicine.org)
- Accurate treatment of thyroid disorders often requires collaborating with different areas and specialties, including the Johns Hopkins Thyroid Tumor Center . (hopkinsmedicine.org)
- Our thyroid team is made up of world-class endocrinologists, specialists and researchers, including the director of the Division of Endocrinology, Diabetes and Metabolism, the current chair of the Subspecialty Board for Endocrinology, Diabetes and Metabolism, and a recipient of the American Thyroid Association's Distinguished Service Award. (hopkinsmedicine.org)
- The medical specialists in the Thyroid Tumor Center offer comprehensive treatment for all of your thyroid disorder-related needs. (hopkinsmedicine.org)
- Along with providing patient care, we also perform clinical and molecular biology research into the causes, effects and treatment of thyroid disorders such as molecular markers of thyroid cancer and clinical studies of patients with hyperparathyroidism. (hopkinsmedicine.org)
- It secretes thyroid hormones that play an essential role in regulating metabolism. (nutriwins.com)
High phosphorus1
- Decreased PTH levels lead to low calcium levels and high phosphorus levels in the blood. (nih.gov)
Hypocalcemia2
- In CKD, hyperphosphatemia and hypocalcemia occur due to loss of renal function, deficit of active vitamin D, and imbalance in the maintenance of the calcium-phosphorus product. (alliedacademies.org)
- Parturient paresis in pregnant and lactating ewes and does is a disturbance of metabolism characterized by acute-onset hypocalcemia and rapid development of hyperexcitability and ataxia, progressing to depression, recumbency, coma, and death. (merckvetmanual.com)
Homeostasis2
- The kidneys, bones, and intestines regulate phosphorus homeostasis, which requires maintenance of urinary losses at equivalent levels to net phosphorus absorption and ensuring that equal amounts of phosphorus are deposited and resorbed from bone [ 1 , 7 , 8 ]. (nih.gov)
- Several hormones, including estrogen and adrenaline, also affect phosphorus homeostasis. (nih.gov)
Patients11
- MEN Type 1 is an autosomal dominant disorder and the most common hereditary form of hyperparathyroidism, affecting about 95% of genetic cases of OFC, and also tends to affect younger patients than other forms. (wikipedia.org)
- [ 1 ] This disorder is more common in patients with tetraplegia than it is in persons with paraplegia. (medscape.com)
- The objective of the HiLo trial is to determine whether the current practice of normalizing phosphorus significantly reduces morbidity and mortality in chronic hemodialysis patients. (nih.gov)
- The Department of Nephrology at Medeor Hospital, Abu Dhabi, provides exceptional care and service for patients with kidney diseases and disorders, treating both adults and children. (medeor.ae)
- Levels of calcium, phosphorus and intact PTH (PTHi) should be determined in all patients with CKD in which the Glomerular Filtration Rate (GFR) is below 60 mL/min/1.73 m2. (alliedacademies.org)
- 5 ]. These measures should be even more frequent in renal transplant patients or in any patient with CKD who is being treated for disorders of calcium and phosphorus metabolism. (alliedacademies.org)
- The drug effectively relieves spasmodic conditions, and is also taken during the rehabilitation period by patients who have had cardiovascular and gastrointestinal diseases, trauma and nervous disorders. (abchealthonline.com)
- To detect and characterise enterovirus RNA in skeletal muscle from patients with chronic fatigue syndrome (CFS) and to compare efficiency of muscle energy metabolism in enterovirus positive and negative CFS patients. (bmj.com)
- They have published numerous articles and textbook chapters based on their research in metabolic bone disorders and enjoy working with patients to individually tailor effective diet, lifestyle and treatment regimens to improve skeletal health. (hopkinsmedicine.org)
- Since 2008, he has been engaged in disorders of phosphorus-calcium metabolism in patients with chronic kidney disease (predialysis, dialysis stages and after kidney transplantation) in the National Research Center of Endocrinology. (mknc.ru)
- From 2011 to 2013, she studied hormonal and metabolic disorders (phosphorus-calcium, carbohydrate, lipid, purine metabolism) in patients with urolithiasis at the Research Institute of Uronephrology and Human Reproductive Health of the I. M. Sechenov Moscow State Medical University. (mknc.ru)
Mineral4
- Phosphorus is a mineral the body needs to build strong bones and teeth. (medlineplus.gov)
- Phosphorus, an essential mineral, is naturally present in many foods and available as a dietary supplement. (nih.gov)
- The study population will include participants with known or suspected bone disease and/or with a known or suspected disorder of mineral metabolism. (nih.gov)
- Mineral and bone disorders are important complications of this disease, which can result in numerous consequences, such as bone pain, skeletal deformities, bone fractures, vascular calcification, cardiovascular disease and even death [ 3 , 4 ]. (alliedacademies.org)
Kidneys1
- Hereditary forms of hypophosphatemic rickets may be due to abnormalities of vitamin D metabolism or recognition, or due to a decrease in tubular reabsorption of phosphorus in the kidneys. (uchicago.edu)
Glucose2
- Disorders of carbohydrate metabolism: diabetes mellitus types 1 and 2, impaired glucose tolerance, impaired fasting glycemia. (mknc.ru)
- Provides support for healthy glucose metabolism. (306fitness.com)
Mmol1
- 2.5 mg/dL (0.81 mmol/L). Causes include alcohol use disorder, burns, starvation, and diuretic use. (msdmanuals.com)
Skeletal disorder3
- Osteitis fibrosa cystica (/ˌɒstiˈaɪtɪs faɪˈbroʊsə ˈsɪstɪkə/ OSS-tee-EYE-tis fy-BROH-sə SIS-tik-ə) is a skeletal disorder resulting in a loss of bone mass, a weakening of the bones as their calcified supporting structures are replaced with fibrous tissue (peritrabecular fibrosis), and the formation of cyst-like brown tumors in and around the bone. (wikipedia.org)
- Osteoporosis is a systemic skeletal disorder, characterized by reduced bone mass, deterioration of bone structure, increased bone fragility, and increased fracture risk. (biomedcentral.com)
- Several osteoporosis-risk factors have been confirmed in the US and western Europe, but in El Salvador there are neither reliable epidemiological statistics about this skeletal disorder nor studies addressing osteoporosis-risk factors in women. (biomedcentral.com)
Immunology1
- The metabolism and Immunology of bone. (juanncorpas.edu.co)
Pituitary1
- Lead by Dr. Roberto Salvatori, the Johns Hopkins Pituitary Tumor Center is a world-class, multidisciplinary center of experts, diagnosing and treating all types of pituitary disorders, including pituitary tumors, adenomas, craniopharyngiomas, Rathke's cleft cysts and pituitary gland disorders. (hopkinsmedicine.org)
Endocrine2
- Disorders such as familial hyperparathyroidism, multiple endocrine neoplasia type 1 (MEN Type 1) and hyperparathyroidism-jaw tumor syndrome can, if left unchecked, result in OFC. (wikipedia.org)
- Pediatric Endocrine Disorders , since its very first edition in 2001, has firmly established its place as a core learning resource for postgraduate students and trainees in pediatric endocrinology as well as endocrinology. (orientblackswan.com)
Osteoporosis2
- Our doctors understand metabolic bone disorders, and they have years of clinical expertise in endocrinology, metabolic bone disorders, osteoporosis, vitamin D deficiency, and calcium and phosphorus disorders. (hopkinsmedicine.org)
- Teniendo en cuenta lo anterior esta revisión buscó plasmar el estado del arte y los conceptos más recientes sobre el uso de Calcio en la osteoporosis asà como establecer si el riesgo cardiovascular atribuido a este agente es real. (juanncorpas.edu.co)
Diseases2
- Imprinting disorders (IDs) are a group of congenital diseases characterised by overlapping clinical features affecting growth, development and metabolism, and common molecular disturbances, affecting genomically imprinted chromosomal regions and genes. (biomedcentral.com)
- BENEFITS -:Amla Candy is a good source of vitamin C, iron and minerals, it helps to boost immunity, regulates metabolism, helps in hyperacidity, eye ailments, skin diseases, anemia and blood-related disorders. (indianshopy.com)
Diabetes2
- The Johns Hopkins Division of Endocrinology, Diabetes, and Metabolism provides innovative diagnosis and treatment options for a range of endocrinology-related disorders. (hopkinsmedicine.org)
- Consult a healthcare practitioner prior to use if you have a liver disorder, cardiovascular disease, kidney disorder and/or diabetes. (306fitness.com)
Absorption4
- Because human intestines lack the phytase enzyme, much phosphorus in this form is unavailable for absorption [ 1 ]. (nih.gov)
- Phosphorus undergoes passive absorption in the small intestine, although some is absorbed by active transport [ 2 ]. (nih.gov)
- Disorders in the processing of phosphorus in the body: its absorption, transport, storage, and utilization. (nih.gov)
- Helps in the absorption and use of calcium and phosphorus. (306fitness.com)
Minerals1
- Amla is rich in minerals and vitamins such as carotene, phosphorus, calcium, iron, and vitamin B complex hence, it is a powerful antioxidant. (indianshopy.com)
Adrenal4
- Why choose Johns Hopkins for treatment of an adrenal disorder? (hopkinsmedicine.org)
- Essential to receiving the right care for your adrenal disorder is connecting with a doctor who understands your needs, is compassionate and is skilled at treating your particular illness. (hopkinsmedicine.org)
- Our doctors are experienced in providing personalized care for adrenal disorders, including those disorders that aren't necessarily treated by other doctors. (hopkinsmedicine.org)
- Accurate diagnosis of adrenal disease can be challenging, and our doctors believe that comprehensive, collaborative approaches to treating adrenal disorders lead to the best outcomes. (hopkinsmedicine.org)
Boosts2
- Boosts metabolism. (planetayurveda.com)
- The nutrient boosts your metabolism and burns unwanted fats. (amazonthunder.com)
Strengthens1
- It is rich in calcium and phosphorus strengthens bones, joints. (planetayurveda.com)
Aromatic1
- Although little is known about the metabolism of the substituted aromatic herbicides dicamba and pendimethalin in humans or surrogate animals, they are of low acute toxicity tomammalsand not previously known to be carcinogenic. (cdc.gov)
Rickets1
- Additionally, hypophosphatasia, a condition caused by deficient activity of tissue-nonspecific isozyme of alkaline phosphatase (TNSALP), may have rickets as a characteristic in the neonatal, infantile and childhood forms of the disorder. (uchicago.edu)
Hypoparathyroidism1
- Hypoparathyroidism is a rare disorder of calcium metabolism. (nih.gov)
Zinc1
- They are also rich in magnesium, iron, calcium, phosphorus, and zinc.2.Rich in Amino AcidsMoringa leaves are rich in amino acids, the building blocks of proteins. (dongyuanbiotech.com)
Regulates1
- PTH regulates the amount of calcium and phosphorus in the blood through its direct effects on the kidney and bone, where the body stores most of its calcium. (nih.gov)
Hormone1
- Dr. Adrian Dobs is an active investigator in the field of male and female sex hormone disorders. (hopkinsmedicine.org)
Dietary3
- Intake recommendations for phosphorus and other nutrients are provided in the Dietary Reference Intakes (DRIs) developed by the Food and Nutrition Board (FNB) at the National Academies of Sciences, Engineering, and Medicine [ 12 ]. (nih.gov)
- Also, in accordance with the instructions, Magnesium is effective in dietary programs for weight loss and normalization of metabolism. (abchealthonline.com)
- Most grains also contain minimal calcium but additionally have high levels of phosphorus, causing an inverse calcium:phosphorus ratio, increasing dietary risk. (merckvetmanual.com)
Levels1
- PTH maintains normal blood levels of calcium, phosphorus, and magnesium through its actions on the bone and kidney. (nih.gov)
Tobacco Use Disorder1
- Dr. Anaba works at Practice in Alexandria, LA with other offices in Centerville, OH, Longview, TX and Covington, GA. They frequently treat conditions like Tobacco Use Disorder along with other conditions at varying frequencies. (healthline.com)
Imbalance2
- An imbalance between calcium and phosphorus can indicate and issue with skeletal and cardiovascular in nature (Sun et al. (sunshinehealthandnutrition.com.au)
- An imbalance between magnesium and calcium can indicate an issue with blood sugar regulation (Barbagallo, 2015), metabolic, inflammatory, and cardiovascular disorders (Afonso et al. (sunshinehealthandnutrition.com.au)
Complication2
Body3
- Metabolism is the process your body uses to get or make energy from the food you eat. (icd9data.com)
- Phosphorus is one of the most abundant elements in the human body. (msdmanuals.com)
- It hydrates our body and corrects metabolism. (planetayurveda.com)